Several lytic mediators of CTL and NK cells have been described, including a pore-forming protein (PFP, perforin or cytolysin) t contained in their cytoplasmic granules (1-4). PFP/perforin is known to lyse a variety of cellular targets with little cell type specificity.
ated (3,000 rad) spleen cells obtained from CD2F, (H2d) at a responder/stimulator ratio of 1 :1 . The mixed cell populations at 5 x 106/ml were cultured in aMEM/5% FCS/5 x 10-5 M 2-ME for the indicated times, after which cells were washed three times and resuspended in aMEM/5% FCS and used as effector cells . In some experiments, mixed cell populations were harvested, resuspended in serum-free medium, and then treated with perforin or control buffer before their use as effector cells .
To prepare murine lymphokine-activated killer (LAK)/NK cells, spleen cells were prepared as before, with the exception that the incubation medium contained 1,000 U/ml of human rIL-2 (generously provided by Cetus Corp., Emeryville, CA) . NK cells were obtained asplasticadherent cells after rIL-2 stimulation, essentially as described (19) .
Human Lymphocyte Subsets. Human PBMC were isolated by Ficoll-Hypaque gradient centrifugation from leukocyte concentrates obtained in plateletpheresis bags (New York Blood Center, New York, NY) . Monocytes and B lymphocytes were removed by adherence to plastic dishes and to nylon-wool columns, respectively (20) . Nylon wool-nonadherent lymphocytes were washed and resuspended in RPMI 1640/10% FCS . A panning procedure was used to enrich for NK, CD4', and CD8' cells . Briefly, cells were incubated with OKT3 hybridoma supernatant (1 :3 dilution) for 1 h at 4°C, washed three times, and resuspended to 3 x 106 cells/ml in RPMI 1640/FCS. Cells were then plated in petri dishes precoated with goat anti-murine IgG (120 ug per 60 x 15 mm petri dish). Plates were then centrifuged at 40 g for 4 min and incubated at 4°C for 60 min, after which the nonadherent cells were collected and washed three times with RPMI 1640. This cell population was enriched for NK cell phenotype and typically contained >95% of cells staining positive for the NK cell marker B73 .1, as determined by FAGS analysis. The plates containing adherent cells were incubated for an additional 3 h at 37°C, after which plate-adherent cells were collected . Stimulation of human LAK/NK cells with rIL-2 was performed as for murine cells, at 1,000 U of rIL-2 per milliliter.
Purification ofPFPIPerforin. Perforin was purified from CTLL-R8 cells by a procedure outlined elsewhere (21) . Briefly, perforin from granule-enriched material was purified sequentially on DEAE-Sepharose, Q Sepharose, mono Q, and Superose 12 columns adapted to an FPLC system (Pharmacia Fine Chemicals, Uppsala, Sweden) . The purified protein migrated as a single band of 70 kD when analyzed on SDS-polyacrylamide gels performed under disulfide-reducing conditions and stained with silver nitrate (not shown). Human perforin activity was obtained from peripheral blood NK cells essentially as described (21) .
Hemolysis Assay for Perforin. A hemolysis microassay (15) was used to measure perforin activity. SRBC were used as targets at 108 cells/ml in PBS; 200 pl of SRBC suspension per microtiter well was tested in triplicates against 20 p,l of lytic reagent in the presence of 1 mM CaC12 (14) . Hemolysis was determined after a 30-min incubation at 37°C by spectrophotometric reading ofthe plates at 700 nm. The extent of hemolysis was given as percent hemolysis by [1 -(b-c)/(a-c)] x 100, where a represents At00 of the intact SRBC suspension, b the A7oo of the lysed erythrocyte suspension, and c the A700 of the SRBC suspension completely lysed with water. One hemolytic unit (HU) is defined as the amount of perforin required to lyse 50% of 2 x 107 SRBC in a total volume of 220 pl. The specific activity of purified perforin used in most of the experiments was ti150 HU/kg protein .
"Cr-Release Assay. Target cell lines at 2 x 106/ml were incubated in 1 ml of FCS containing 100 uCi of Na25'CrO4 (New England Nuclear, Boston, MA) at 37'C for 2 h with occasional mixing. For primary cells, labeling was done in aMEM/5% FCS for 5 h at 37°C . Labeled cells were then washed in aMEM three times and resuspended to 105 cells/ml in serum-free aMEM. For measurement of perforin-induced cytotoxicity, 104 5'Cr-labeled cells were incubated with the indicated amounts ofperforin in a final volume of 200 p.l per microtiter well, followed by a 4-h incubation at 37°C. After the incubation, the plates were centrifuged at 200 g for 5 min and 100 A1 of the supernatant was removed from each well for determination of the radioactivity in a gamma counter. To measure the cytotoxic activity of CTL hybridomas or primary killer cells, 104 "Cr-labeled target cells resuspended in ceMEM/10% FCS were mixed with appropriate effector cells at indicated E/T ratios in a round-bottomed microwell in a total volume of 200 pl, followed by a 5-h incubation at 37°C. In some experiments, the cytotoxic reaction mediated by primary spleen cytotoxic cells was carried out in medium containing 5 wg/ml ofCon A. The percent cytotoxicity is calculated as : 100 x [(experimental "Cr release -spontaneous "Cr release)/(total ''Cr release -spontaneous "'Cr release)] . "Cr release by target cells cultured in medium alone was taken as spontaneous release, while "Cr release by target cells lysed with 1% NP-40 was measured as total release .
Induction of Cytotoxic Activity in CTL Hybridomas . For induction of cytotoxic activity, Md90 cells were treated with 5 Fog/ml of Con A for the indicated periods of time at 37°C, washed three times in ceMEM containing 1 leg/ml a-methyl manoside, and immediately used either as effectors or as targets after "Cr labeling as described above. For antigenic stimulation, hybridomas M8 .23, PMM1, and Md26 .9 were cocultured with 4,000-rad irradiated EL-4 cells at the hybridoma/target ratio of 2 :1 for 20 h (18) ; cells were then washed and used as effectors against "Cr-labeled EL-4 target cells .
Reatment of CTL with Protein and RNA Synthesis Blockers . Md90 hybridomas were activated as described above in the presence of 10 l~g/ml of cycloheximide (CHX) (Sigma Chemical Co., St . Louis, MO) . To ensure complete termination of protein synthesis before the activation event, Md90 cells were incubated with CHX for 30 min before stimulation with Con A or EL-4 cells and for the duration of the subsequent cytotoxicity assays in which MOO cells were tested . In experiments using emetine (Sigma Chemical Co.), an irreversible protein synthesis inhibitor, CTL hybridomas, and cloned CTLs were pretreated with 5 x 10 -6 M of emetine for 30 min, washed three times for removal of any residual emetine, and then subjected to induction . "Cr labeling and cytotoxic reaction were performed exactly as described above . In some experiments, emetine was present throughout the induction period and the cytotoxicity assay. Alternatively, cells were induced in the presence of actinomycin D (actD; Sigma Chemical Co.), an RNA synthesis inhibitor, and processed for functional assays exactly as described above . Viability of cells was given by trypan blue exclusion .
PSJMethionine Labeling of Cells. [ 
Results
Effect ofPurified Perforin on Cloned CTL. Although previous studies indicated that cloned CTL are resistant to granule-mediated killing, it was not clear whether primary cytotoxic cells are also resistant to the lytic effect of the pore-forming protein perforin . For the present study, purified perforin was obtained from murine CTLL-RS after several steps of liquid chromatography (Materials and Methods) . The membrane-lytic activity of this purified material was ascertained through hemolytic assays (used to define lytic activity in hemolytic units) and through "Cr-release cytotoxicity assays for nucleated target cells . Fig . 1 illustrates the typical dose-dependent cytotoxic effect of purified perforin on P815 mastocytoma and YAC-1 lymphoma cells . While both targets were susceptible to perforin, in parallel assays, perform lysed poorly CTLL-1 (a perforin nonproducer) and did not produce any measurable cytotoxicity on CTLL-R8 ( with perforin-enriched granules (10), suggesting that the CTL lines tested are also resistant to purified perforin . Purified perforin was next used to assess the resistance of primary cytotoxic cells to perforin-mediated killing.
Effect of Purified Perforin on Primary Cytotoxic Cells. Primary cytotoxic lymphocyte populations were generated by culturing spleen cell populations obtained from CD2F1 mice in the presence of IL-2-containing leukocyte-conditioned medium (Materials and Methods) . Cells stimulated for 1-5 d in this conditioned medium were tested as effectors against EL-4 targets in a lectin-dependent cell-mediated cytotoxicity (LDCC) assay (Fig. 2 a) . This assay measures the development ofnonspecific effector cells that are triggered to lyse targets to which they bind via a lectin-dependent mechanism. The results showed clearly that cytotoxicity increased with the number of days that spleen cells were stimulated with leukocyte-conditioned medium. The relatively high E/T ratio required to achieve any substantial amount of cell lysis ( Fig.  2 a) was probably due to the fact that bulk unfractionated spleen cell populations containing also non-killer cells were used for these experiments .
Spleen cells stimulated with leukocyte-conditioned medium were labeled with "Cr and used as target cells for purified perforin . A marked increase in cellular resistance against perforin-mediated lysis was observed 24 h after stimulation with conditioned medium, and resistance increased steadily from day 1 to day 5 of culture (Fig. 2 b) . After 5 d of in vitro stimulation, <10% of spleen cells were lysed by 30 HU of perforin (Fig. 2 b) , corresponding to the resistance level observed with cloned CTLL. In parallel experiments in which spleen cells were cultured in the absence of leukocyte-conditioned medium, cells remained highly susceptible to perforin-mediated lysis (Fig. 2 c) . However, the viability of cells in the absence of leukocyte-conditioned medium decreased to <30% on the third day of culture, as determined by trypan blue exclusion; moreover, the remaining viable cells labeled poorly with "Cr (not shown) . Thus, a direct comparison between the resistance of stimulated and unstimulated spleen cells could only be made during the first 2 d of culture (Fig . 2, b vs. c) .
The cell type distribution of spleen cells cultured in vitro was studied by FAGS analysis using mAbs directed against L3T4 (CD4) and Lyt-2 (CD8) (not shown) .
After stimulation with leukocyte-conditioned medium, the percentage of Lyt-2+ cells increased from 18% (range 9-27%) on day 0 (before treatment) to 66% (range 41-90%) on day 5, corresponding to approximately a fivefold increase . The percentage of L3T4+ cells, on the other hand, decreased from 57% (45-69%) on day 0 to 13% (range 8-17 17 ,o) on day 5 . Unstimulated cells, however, did not show significant change during the first 2 d of culture in their relative distribution ofLyt-2 and L3T4 phenotypes . Since Lyt-2+ cells include CTL, our results suggest further that an increase in cell resistance to perform may correlate with an increase in the number of CTL in the bulk spleen population .
Primary CTL were also obtained through an MLC reaction (H2' anti-H2' and H2k anti-H2 d). MLC-derived bulk spleen cell populations were either treated with perforin or control buffer (Table I) . The rationale of these experiments was based on the premise that if primary alloimmune CTL were resistant to perforin, then perforin-treated cells would retain cytotoxic activity toward allospecific targets. Thus, perforin-treated and control cells were used as effectors against P815 mastocytoma targets (H2d). The data summarized in Table I show that although 30-69% of spleen cells were lysed in different experiments by various doses of perforin, perforintreated cells could still lyse P815 as effectively as untreated MLC-activated cells, suggesting that the perforin-resistant cells were also the cells with cytotoxic capability. Perforin-resistant cells must have represented mostly allospecific CTL since they killed MHC-imcompatible target cells poorly (e.g., only up to 8% of YAC-1 [H2a] were killed at an E/T ratio of 50 :1).
To further verify the phenotype ofthe perforin-resistant cells, a panning technique was used to separate B, L3T4+, and Lyt-2' lymphocytes, which were then tested for their sensitivity to perforin-mediated lysis. As shown in Fig. 3 , B and L3T4', but not Lyt-2 + , lymphocytes were readily lysed by perforin, indicating that even unstimulated CTL (e.g., cells of Lyt-2 + phenotype) were the least sensitive to perforin-mediated killing when compared with other lymphocyte subsets.
In another set of experiments, perforin was also tested against PEL obtained from mice undergoing rejection of MHC-incompatible tumors (Materials and Methods). PEL were also significantly more resistant to perforin-mediated lysis when compared with peritoneal macrophages or B cells (data not shown) .
Resistance ofPrimary NK/LAK Cells to Perforin-mediated Killing. Primary NK/LAK cells from mouse spleen were obtained by stimulation of spleen cells with high con- Murine Lyt-2' lymphocytes are least susceptible to perforin-mediated lysis . Murine spleen cells were fractionated by a panning procedure (see Materials and Methods), labeled with S 'Cr, and incubated in triplicate for 4 h with varying doses of perforin . The spontaneous release was <15% . Methods). IL-2-stimulated NK cells, but not plastic-nonadherent cells, effectively killed NK-sensitive YAC-1 cells (Fig. 4 a) . In parallel experiments, stimulated NK cells, but not plastic-nonadherent cells, were shown to be markedly resistant to perforinmediated killing (Fig. 4 b; only data for cells stimulated with rIL-2 for 4 d shown here). These experiments suggest that both primary CTL and NK cells are resistant to perforin-mediated lysis. We also studied the resistance of human peripheral blood-derived primary CTL and NK cells to lysis mediated by human perforin . Human NK cells isolated by a panning procedure (Materials and Methods) were stimulated with 1,000 U of rIL-2 for 2 or 4 d. This treatment increased significantly the cytotoxicity of stimulated cells against the K562 target, an NK-sensitive tumor (Fig. 5 a) . IL-2-stimulated cells also became progressively resistant to the lytic effect of human perforin when tested .
In parallel experiments, purified murine perforin was tested against human NK cells (Fig (Fig. 6, b and c) . A marked increase in PFP/perforin and BLTesterase content was found in the R8i cell lysates (15-20-fold increase of PFP and 4-fold increase of BLTesterase after stimulation for 24 h ; Fig. 6 , b and c, shows data only for rIL-2 stimulation) . These observations suggest that, like the resistance phenotype, the production ofgranule contents in perforin-containing cells may also be induced without concomitant cell proliferation. The IL-2-independent CTL hybridoma Md90 has previously been shown to acquire cytotoxicity gradually in 4-20 h after stimulation with the lectin Con A (18). This time-dependent activation of Md90 cells was confirmed in the present studies using Con A at 5 ug/ml (not shown) . In parallel experiments, Md90 cells were shown to acquire partial resistance to perforin after Con A stimulation (Fig. 7) . The time courses for development of cytotoxicity and resistance were comparable .
Two other IL-2-independent CTL hybridomas, M8 .23 and PMM 1, were also tested . Upon incubation with irradiated EL-4 cells, both CTL hybridomas became more efficient killers as well as more resistant to perforin (Table II) . However, a subclone of M-hybridomas, Md26 .9, which could not be induced to become cytotoxic (Kaufmann, Y., et al., manuscript in preparation), did not become significantly more resistant to perforin-mediated lysis under stimulation (Table II) .
Protein Synthesis Is not Requiredfor Induction of Resistance. Resistance induction in R8i and CTLT hybrids was next carried out in the presence of either CHX (10 tug/ml for Md90, and 2 jug/ml for CTLL-R8i) or emetine (50 uM), an irreversible protein synthesis blocker (Table III) . In the presence ofeither one of the two inhibitors, induction ofboth resistance and cytotoxicity was unaltered (Table III) . To ascertain that CHX and emetine were effective at the doses used, cells were biosynthetically labeled with ["S]methionine either in the presence or absence of the inhibitor (Table IV) . The amount ofradiolabeled proteins was then determined by TCA precipitation . These experiments revealed that CHX or emetine blocked 81-95% (range of three experiments) of 35S incorporation into cellular proteins . To further ensure that conditions used here were optimal for inhibition of protein synthesis, the inhibitor was added 30 min before the addition of cell induction reagents (IL-2 in the case of R8i and Con A for Md90 cells) . This type of treatment was also ineffective in blocking resistance induction. 7 . The CTL hybridoma Md90 acquires partial resistance to perforinmediated lysis upon activation with Con A. Md90 cells were stimulated with 5 hg/ml of Con A for the indicated periods of time, after which cells were labeledwith "Cr and used as targets for purified perforin in a 4-h cytotoxicity assay. Each data point represents average of triplicates. CTL hybridoma Md90 was stimulated with 5 kg/ml of Con A for 8 h, while CTLL-R8i was treated with rIL-2 for 24 h . : CHX was used at 1014g/ml for Md90 cells and 2 Ag/ml for CTLL-R8i . Emetine was used at 5 x 10 -5 M . ActD was used at 1 /~g/ml . 
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RNA synthesis also appeared not to be required for the induction of resistance in cytotoxic cells. This conclusion was inferred from experiments in which actD was added at 1 Wg/ml, while CTL hybridoma Md90 and R8i were induced as before (Table III) . Although actD effectively interrupted [3H]thymidine incorporation into treated R8i or Md90 cells (90-95% inhibition), this treatment did not affect the resistance increase in these cells seen after activation (Table III) the distribution of this protein in various cytolytic cell types (24) (25) (26) , there is little doubt that perforin is among the more potent mammalian cytotoxins isolated to date . $y growing large numbers of CTL and NK cells in vitro, it is possible now to obtain purified perforin in amounts sufficient for biochemical and functional studies.
Using purified perforin, we have shown here that both cloned CTL and primary killer cell populations, including allospecific CTL, NK/LAK cells, and MHC-nonrestricted CTL, are more resistant to perforin-mediated killing than other lymphocyte populations. The resistance of killer cells to perform appears to correlate with their cytolytic capability, i.e., cells that are or have become competent killers are also the more resistant cells. For a given cytolytic cell population, resistance and cytotoxicity are shown to increase simultaneously after stimulation with certain reagents such as IL-2 or leukocyte-conditioned medium. The acquisition of resistance to perforin-mediated lysis is independent of the induction ofcell proliferation, since IL-2-independent CTL lines and hybridomas, when triggered to become cytotoxic, acquire perforin resistance . It should be pointed out that the acquired resistance to perforin is not complete and that the resistance can be overcome with high doses of perforin .
Whether cells are required to produce perforin in order to become perform resistant is not clear yet. Of the primary cytolytic populations tested, only cells that have been activated directly with IL-2 acquire measurable levels of perforin (our unpublished observations ; see also references 24-27) . CTL activated through MLC do not appear to produce any measurable levels of perform (reference 25 and our unpublished observations), while they do become partially perforin resistant. The various CTL hybridomas tested also acquire resistance upon stimulation with Con A and APCs . However, our preliminary studies show that they do not produce any measurable amounts ofperforin upon activation . Several perforin-nonproducer CTLL, such as CTLL-1 shown here, have remained perforin resistant . Experiments with PEL also indicate that while these cells do not produce measurable amounts of perforin, they become resistant to killing induced by other CTL and by perforin (data not shown) . Another more recent study by Nagler-Anderson et al . (28) also showed that primary CD8+ T cells elicited in vivo or in vitro are more resistant than CD4+ T cells and non-T cells to lysis mediated by CTL granules. Since primary CD8 + cells are now known to be perforin-negative under the conditions studied by these authors, together these results imply that the acquisition of resistance to perforin may be dissociated from the production of perforin in the same cells. More experiments are required, however, to substantiate this statement.
Our analysis of the IL-2-independent CTL variant R8i indicates that IL-2 may supply the necessary signal in this case to induce cells to produce perforin as well as to acquire the perforin-resistant phenotype. How this could occur without concomitant protein and/or RNA neosynthesis remains a puzzling finding. These results do not rule out, however, that a post-translational event or modification may be involved in the development of the resistance phenotype.
While perforin-treated primary killer cells were shown here to retain their capability to kill targets, it should be pointed out that in another study (29) we have shown that CTL granules contain an inhibitory activity, distinct from perforin, that is capable ofinactivating reversibly the lytic activity ofCTL. Accordingly, we confirmed here that perforin is not responsible for this inhibitory activity present in the granules .
We are currently attempting to dissect further the molecular details underlying the lymphocyte resistance to perforin . In two previous reports (30, 31) , human lymphocytes were shown to acquire resistance to perforin upon stimulation with anti-CD3 antibodies . The reports by the same group also showed an augmented expression of homologous restriction factor (HRF) (31, 32) (also named C8/C9-binding protein [32, 33] ) on lymphocyte surface after stimulation with antibodies specific for CD3, and the authors suggested that HRF is the molecular species responsible for self-protection of lymphocytes (34) . This conclusion is not supported by our own studies, which have demonstrated that the phenomenon of homologous species restriction, while applicable to complement-mediated lysis, is not observed in the lymphocyte perforin system (12) . Thus, although murine perforin lyses poorly, or not at all, homologous and heterologous cytotoxic lymphocyte populations, it lyses very well noncytotoxic cell targets of various species (including the homologous species) that nevertheless contain HRF Here we have also shown that both murine and human LAK/NK cells, upon rIL-2 stimulation, become more resistant to murine perforin, further indicating that the lymphocyte resistance to perforin is not restricted to the perforin of homologous species. We hypothesize that other molecules/mechanisms must be involved in conferring resistance to lymphocytes against perforin-mediated lysis. Current studies in our laboratories are directed towards elucidating these mechanisms.
Summary
CTL and NK cells cultured in vitro are known to produce a cytolytic pore-forming protein (PFP, perforin) localized in their cytoplasmic granules . Using purified perforin, we showed here that both cloned CTL and primary killer cell populations, including allospecific CTL, NK/lymphokine-activated killer cells, and MHC-nonrestricted CTL, were more resistant to perforin-mediated killing than other lymphocyte populations and cell types. Similar results were obtained with both murine and human cytolytic lymphocyte populations. Resistance of killer cells to perforin correlated in general with their cytolytic capability. Thus, cells that have acquired competence to kill after stimulation with Con A, IL-2, or leukocyte-conditioned medium, were also the more resistant cells. IL-2-independent CTL lines and hybridomas derived in our laboratories could be triggered to become cytotoxic and perforin resistant by short-term stimulation with various cytokines, indicating that the acquisition of resistance to perforin-mediated lysis was independent of cell proliferation. Activation of one IL-2-independent CTL line with IL-2 also resulted in enhanced production of perforin and in enhanced serine esterase activity. The acquisition of cell resistance to perforin by these IL-2-independent cell lines after activation with stimulatory reagents was independent of protein and RNA neosynthesis : emetine, cycloheximide, and actinomycin D, while effectively blocking the incorporation of [35 S]methionine into cell proteins, did not affect the induced increase in perforin resistance.
